| Epilepsy |
1 |
1 |
| Pharmacokinetics |
0 |
0.6 |
| Thromboembolism |
0 |
0.59 |
| Atrial Fibrillation |
0 |
0.54 |
| Anticoagulation Therapy |
0 |
0.99 |
| Match |
0 |
0.38 |
| Salary and Compensation |
0 |
0.3 |
| Medical Life |
0 |
0.23 |
| Patient Safety |
0 |
0.17 |
| Revenue and Practice Management |
0 |
0.17 |
| Adverse Effects |
0 |
0.15 |
| Animal Research |
0 |
0.15 |
| Cerebrovascular Accident |
0 |
0.15 |
| Cyclooxygenase (COX) |
0 |
0.15 |
| Drug and Treatment Safety |
0 |
0.15 |
| Drug Costs |
0 |
0.15 |
| Embolism |
0 |
0.15 |
| Epidemiology |
0 |
0.15 |
| Illinois |
0 |
0.15 |
| Massachusetts |
0 |
0.15 |
| Metabolism |
0 |
0.15 |
| Peer Review |
0 |
0.15 |
| Pennsylvania |
0 |
0.15 |
| Stress |
0 |
0.15 |
| Students |
0 |
0.15 |
| Vein |
0 |
0.15 |
| Vitamin |
0 |
0.15 |
| Pulmonary Embolism |
0 |
0.12 |
| Deep Venous Thrombosis |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |